PlainRecalls

Pharmacy Innovations

Compiled from official public sources by the publisher.

59 recalls on record · Latest: Feb 1, 2023

Subscribe to new Pharmacy Innovations recalls (RSS)

Agency notice ledger

Federal filing book Pharmacy Innovations MID-BOOK · SINGLE-AGENCY

#302 of 14,151 · 59 notices · 0.057% archive

  • BOOK 59 notices
  • RANK #302 of 14,151
  • SHARE 0.057% archive
  • AGENCY FDA Drug (59)
  • CAT drugs
  • CATS 3 categories
  • LATEST Feb 1, 2023
  • PHOTO American Health Packa…

Nearest notice-volume peer: American Health Packaging (0 notice gap)

Pharmacy Innovations accounts for about 0.057% of the 104,423-notice archive on 59 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Pharmacy Innovations sits among 14,151 recalling firms

Pharmacy Innovations ranks 302nd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Pharmacy Innovations vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

59 302nd of 14151 higher than 13,847 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Pharmacy Innovations in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Pharmacy Innovations holds about 0.057% of archive notices alongside 59 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Feb 1, 2023

GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 31%(V/V)/0.17%/0.00017% (10ML VIALS); GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 48.7%(W/V)/0.67%/0.00067% (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

MAGNESIUM CHLORIDE HEXAHYDRATE-PF- 200MG/ML (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

5-Fluorouracil 1%, 2.5ML droptainer, and 5ML droptainer Ophthalmic, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

Chlorpheniramine/Hyoscyamine (1ML) 10MG/0.25MG/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

Ethyl Alcohol 95% (5ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

LIDOCAINE-PF- 5% (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

DEXAMETHASONE 16MG/ML (3ML VIAL) INJECTABLE; DEXAMETHASONE 24MG/ML INJECTABLE; DEXAMETHASONE-PF- 0.1% (1ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID (10ML VIAL) 50MG/50MG/ML (5%/5%) INJECTABLE; Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
FDA Drug Moderate Feb 1, 2023

GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL, Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

Pharmacy Innovations carries an outsized archive share

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

American Health Packaging 59 Aurobindo Pharma USA Inc 59 Novartis Consumer Health 60 GenoGenix LLC 57

Frequently Asked Questions

How many federal recall notices name Pharmacy Innovations? ▼
PlainRecalls indexes 59 distinct federal recall events naming Pharmacy Innovations, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Pharmacy Innovations sit among other recalling firms? ▼
Pharmacy Innovations ranks #302 of 14,151 by distinct recall-event count among 14,151 firms in this archive (98th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Pharmacy Innovations's notices? ▼
FDA Drug accounts for 59 of this firm's 59 indexed notices.
What product category dominates Pharmacy Innovations's filing book? ▼
Filings for Pharmacy Innovations span 3 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Pharmacy Innovations: 59 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Pharmacy Innovations; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026